phenyl acetate has been researched along with Hepatoblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, GC; Chiang, AK; Liu, AP; See, QW; Wong, KN | 1 |
| Janciauskiene, S; Lindgren, S | 1 |
| Barrett, PH; Huff, MW; Newton, RS; Wilcox, LJ | 1 |
3 other study(ies) available for phenyl acetate and Hepatoblastoma
| Article | Year |
|---|---|
11C-Acetate Positron Emission Tomography for Detection of Occult Metastatic Recurrence in Hepatoblastoma.
Topics: Acetates; Bone Neoplasms; Carbon Radioisotopes; Child; Female; Hepatoblastoma; Humans; Liver Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence | 2016 |
Effects of fibrillar C-terminal fragment of cleaved alpha1-antitrypsin on cholesterol homeostasis in HepG2 cells.
Topics: Acetates; alpha 1-Antitrypsin; Bile Acids and Salts; CCAAT-Enhancer-Binding Proteins; Cholesterol; Cholesterol Esters; DNA-Binding Proteins; Gene Expression; Hepatoblastoma; Homeostasis; Humans; Lipoproteins, LDL; Liver Neoplasms; Nuclear Proteins; Peptide Fragments; Receptors, LDL; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Transcription Factors; Tumor Cells, Cultured | 1999 |
ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Topics: Acetamides; Acetates; Apolipoprotein B-100; Apolipoproteins B; Carbon Radioisotopes; Coenzyme A; Enzyme Inhibitors; Hepatoblastoma; Humans; Hydroxymethylglutaryl CoA Reductases; Intracellular Fluid; Lipid Metabolism; Lipids; Receptors, LDL; RNA, Messenger; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tumor Cells, Cultured | 1999 |